Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Additional file of Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
Fahmin Basher
(Creator)
Payal Dhar
(Creator)
Xin Wang
(Creator)
Derek A. Wainwright
(Creator)
Bin Zhang
(Creator)
Jeffrey Sosman
(Creator)
Zhe Ji
(Creator)
Jennifer Donglan Wu
(Creator)
Northwestern University
Medicine, Hematology Oncology Division
Microbiology-Immunology
Neurological Surgery
Driskill Graduate Training Program in Life Sciences
IIN - International Institute for Nanotechnology
Robert H. Lurie Comprehensive Cancer Center
Pharmacology
Urology
Dataset
Overview
Research Output
(1)
Research output
Research Output per year
2020
2020
2020
1
Article
Research Output per year
Research Output per year
1 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Search results
2020
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
Basher, F., Dhar, P., Wang, X., Wainwright, D. A.,
Zhang, B.
, Sosman, J.,
Ji, Z.
&
Wu, J. D.
,
Jun 9 2020
,
In:
Journal of Hematology and Oncology.
13
,
1
, 74.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Programmed Death-ligand 1 (PD-L1)
100%
Targeted Tumor
100%
Natural Killer Cells
100%
Melanoma
100%
MHC Class II
100%
27
Scopus citations